Dermatomyositis and polymyositis (myositis): vizsgálatok itt: Japán
9 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in JapánA Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies
- Where
- Aichi, Nagoya, Fukuoka, Kitakyushu, Fukushima, Fukushima, Hokkaido, Sapporo, Kanagawa, Kawasaki, Kanagawa, Yokohama, Kyoto, Kyoto, Miyagi, Sendai, Nara, Kashihara, Okayama, Okayama, Osaka, Suita, Tokyo, Bunkyo-ku, Tokyo, Ota-ku, Tokyo, Shinjuku-ku
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07789015 · EU 2026-526365-24-00 - 1. fázisTaking peopleA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Where
- Bunkyō City, Kita-gun, Kitakyushu-shi, Kyoto, Nagasaki
- Életkor
- 18 év to 70 év
- People
- 72 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00 - 3. fázisCsak meghívásosA Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
- Where
- Bunkyō City, Nagoya, Tokyo, Wakayama, Yamaguchi
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- argenx
See details and how to joinNCT05979441 · EU 2022-502851-79-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Where
- Asahikawa-shi, Bunkyō City, Chiba, Fukuoka, Hiroshima, Iruma-Gun, Kawachinagano-shi, Kawasaki-shi, Nagoya, Okayama, Omura-shi, Sendai, Shinjuku-ku, Tachikawa-shi, Yotsukaido-shi
- Életkor
- 18 év to 75 év
- People
- 240 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06455449 - 3. fázisTaking peopleA Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Where
- Bunkyo-ku, Chuo-shi, Kawasaki, Kitakyushu-shi, Okayama, Ōtsu, Sendai, Shinjuku-ku, Ube, Wakayama
- Életkor
- 18 év and over
- People
- 318 worldwide
- Run by
- Pfizer
See details and how to joinNCT05895786 · EU 2022-502739-20-00 - 3. fázisTaking peopleA Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- Where
- Bunkyo-ku
- Életkor
- 18 év and over
- People
- 211 worldwide
- Run by
- Pfizer
See details and how to joinNCT06698796 · EU 2024-514648-10-00 - 1. fázisTaking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Bunkyo-ku, Hamamatsu, Himeji, Isehara, Kodaira, Okayama, Ōta-ku, Sakai, Sapporo, Sendai, Suita, Toyama
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - 1. fázisCsak meghívásosPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Bunkyo-ku, Fukuoka, Hamamatsu, Himeji, Isehara, Kawachi-Nagano, Kodaira, Meguro-Ku, Okayama, Ōta-ku, Sakai, Sapporo, Sendai, Suita, Toyama
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106 - 1. fázisTaking peopleA Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
- Where
- Fukuoka, Hiroshima, Hokkaido
- Életkor
- 18 év to 70 év
- People
- 44 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00